Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.
The report details the trend, potential and market size of Epigenomics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Epigenomicsmarket, defines the market attractiveness level of Epigenomics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Epigenomics industry, describes the types of Epigenomics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Epigenomics market and the development prospects and opportunities of Epigenomics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Epigenomics market in Chapter 13.
By Player:
Novartis AG
Roche Diagnostics
Eisai Co Ltd
Thermo Fisher Scientific, Inc
By Type:
Reagents
Kits
Instruments
Enzymes
Services
By End-User:
Oncology
Non Oncology
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Epigenomics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Epigenomics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Epigenomics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Epigenomics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Epigenomics Market Analysis and Outlook to 2022
-
7.1 Global Epigenomics Consumption (2017-2022)
-
7.2 United States Epigenomics Consumption (2017-2022)
-
7.3 Europe Epigenomics Consumption (2017-2022)
-
7.4 China Epigenomics Consumption (2017-2022)
-
7.5 Japan Epigenomics Consumption (2017-2022)
-
7.6 India Epigenomics Consumption (2017-2022)
-
7.7 South Korea Epigenomics Consumption (2017-2022)
8 Region and Country-wise Epigenomics Market Analysis and Outlook to 2028
-
8.1 Global Epigenomics Consumption Forecast (2022-2028)
-
8.2 United States Epigenomics Consumption Forecast (2022-2028)
-
8.3 Europe Epigenomics Consumption Forecast (2022-2028)
-
8.4 China Epigenomics Consumption Forecast (2022-2028)
-
8.5 Japan Epigenomics Consumption Forecast (2022-2028)
-
8.6 India Epigenomics Consumption Forecast (2022-2028)
-
8.7 South Korea Epigenomics Consumption Forecast (2022-2028)
9 Global Epigenomics Market Outlook by Types and Applications to 2022
-
9.1 Global Epigenomics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Reagents Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Kits Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Instruments Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Enzymes Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Services Consumption and Growth Rate (2017-2022)
-
9.2 Global Epigenomics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Non Oncology Consumption and Growth Rate (2017-2022)
10 Global Epigenomics Market Outlook by Types and Applications to 2028
-
10.1 Global Epigenomics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Reagents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Kits Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Instruments Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Enzymes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Services Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Epigenomics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Non Oncology Consumption Forecast and Growth Rate (2022-2028)
11 Global Epigenomics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Epigenomics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Epigenomics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Epigenomics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Epigenomics Market Competitive Analysis
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Details
-
14.1.2 Novartis AG Epigenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis AG Epigenomics Product and Service
-
14.2 Roche Diagnostics
-
14.2.1 Roche Diagnostics Company Details
-
14.2.2 Roche Diagnostics Epigenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Diagnostics Epigenomics Product and Service
-
14.3 Eisai Co Ltd
-
14.3.1 Eisai Co Ltd Company Details
-
14.3.2 Eisai Co Ltd Epigenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eisai Co Ltd Epigenomics Product and Service
-
14.4 Thermo Fisher Scientific, Inc
-
14.4.1 Thermo Fisher Scientific, Inc Company Details
-
14.4.2 Thermo Fisher Scientific, Inc Epigenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Thermo Fisher Scientific, Inc Epigenomics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Epigenomics
-
Figure Epigenomics Picture
-
Table Global Epigenomics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Epigenomics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Epigenomics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Epigenomics Consumption by Country (2017-2022)
-
Figure United States Epigenomics Consumption and Growth Rate (2017-2022)
-
Table Europe Epigenomics Consumption and Growth Rate (2017-2022)
-
Figure China Epigenomics Consumption and Growth Rate (2017-2022)
-
Figure Japan Epigenomics Consumption and Growth Rate (2017-2022)
-
Figure India Epigenomics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Epigenomics Consumption and Growth Rate (2017-2022)
-
Figure Global Epigenomics Consumption Forecast by Country (2022-2028)
-
Figure United States Epigenomics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Epigenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Epigenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Epigenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Epigenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Epigenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Reagents Consumption and Growth Rate (2017-2022)
-
Figure Global Kits Consumption and Growth Rate (2017-2022)
-
Figure Global Instruments Consumption and Growth Rate (2017-2022)
-
Figure Global Enzymes Consumption and Growth Rate (2017-2022)
-
Figure Global Services Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Non Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Reagents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kits Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Instruments Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzymes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Epigenomics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Epigenomics Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Epigenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Epigenomics Product and Service
-
Table Roche Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Roche Diagnostics Epigenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Diagnostics Epigenomics Product and Service
-
Table Eisai Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Eisai Co Ltd Epigenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Co Ltd Epigenomics Product and Service
-
Table Thermo Fisher Scientific, Inc (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific, Inc Epigenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific, Inc Epigenomics Product and Service
-
